UPZEP 30mg Tirzepatide | Vial

UPZEP 30mg is a multi-dose vial containing 30mg of tirzepatide. Tirzepatide is a dual GIP and GLP-1 receptor agonist that acts on pathways involved in appetite, food intake and blood-glucose regulation.

What UPZEP 30mg Is Used For

Tirzepatide is associated with:

Weight loss and weight management

Helping to reduce appetite and calorie intake

Increasing feelings of fullness and satiety

Supporting improved blood-glucose control

Supporting overall metabolic health

How UPZEP 30mg Works

Tirzepatide activates both GIP and GLP-1 receptors, helping regulate appetite and food intake while improving glucose-dependent insulin secretion.

It also delays gastric emptying, which can contribute to prolonged feelings of fullness.

How to Use UPZEP 30mg

The vial requires appropriate preparation before administration. Use according to the specific product instructions and guidance from a qualified healthcare professional.

Administration Route: Subcutaneous injection.

Dosage Information

Total per vial: 30mg Tirzepatide

Approved tirzepatide regimens are administered once weekly, with gradual dose escalation commonly used to improve tolerability. The appropriate dose should be determined according to individual requirements and professional medical guidance.

Possible Side Effects

Gastrointestinal side effects are among the most commonly reported effects of tirzepatide.

Common

Nausea

Diarrhoea

Decreased appetite

Vomiting

Constipation

Indigestion or abdominal discomfort